A team of residents, faculty, medical students, and researchers at Michigan Medicine’s Department of Family Medicine and Antiracism and Health Equity Program released new findings confirming racial inequities in newborn drug screening. Lauren Oshman, M.D. M.P.H., associate professor of family medicine at the University of Michigan Medical School, discusses the seven-year study and whether newborn drug testing patterns changed after recreational cannabis was legalized in Michigan in 2018. Oshman also explores how the results led to a policy change at Michigan Medicine and the potential reduction of bias in the health system.
